Where Ozempic (semaglutide) is a pure GLP-1 receptor agonist, Retatrutide is a triple agonist working on: GLP-1 improves insulin sensitivity, reduces appetite, slows stomach emptying GIP (Glucose-dependent insulinotropic peptide) enhances insulin secretion, may preserve beta cells, and appears to help prevent the dreaded weight plateau seen with GLP-1 alone Glucagon receptor promotes fat metabolism and increases energy expenditure This means that not only does Retatrutide regulate blood sugar and suppress appetite like Ozempic it also burns more fat and preserves more muscle while you lose weight
Where Can You Safely Inject
It is imperative to deepen our comprehension of the intricate relationship between GLP-1 RAs and psychiatric outcomes, particularly given the substantial association between obesity and psychiatric diseases
Its a precautionary framing, primarily grounded in cancer risk (IARC Group 1 classification)
Purity: 98% (HPLC tested)
Shoppers say they value these services and guidance during times of rapid size change
